5-fluorouracil and gemcitabine potentiate the efficacy of oncolytic herpes viral gene therapy in the treatment of pancreatic cancer
about
Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cellsPromising oncolytic agents for metastatic breast cancer treatmentSynergistic activity of troxacitabine (Troxatyl) and gemcitabine in pancreatic cancerHigh efficiency of alphaviral gene transfer in combination with 5-fluorouracil in a mouse mammary tumor model.Imaging a Genetically Engineered Oncolytic Vaccinia Virus (GLV-1h99) Using a Human Norepinephrine Transporter Reporter Gene.Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer.Oncolytic herpes simplex virus vectors and chemotherapy: are combinatorial strategies more effective for cancer?Oncolytic virotherapy for ovarian carcinomatosis using a replication-selective vaccinia virus armed with a yeast cytosine deaminase geneTargeted oncolytic herpes simplex virus type 1 eradicates experimental pancreatic tumors.Oncolytic herpes simplex virus expressing yeast cytosine deaminase: relationship between viral replication, transgene expression, prodrug bioactivation.Combination of conditionally replicative adenovirus and standard chemotherapies shows synergistic antitumor effect in pancreatic cancerOncolytic herpes viruses, chemotherapeutics, and other cancer drugsGene therapy: the end of the rainbow?Killing of p53-deficient hepatoma cells by parvovirus H-1 and chemotherapeutics requires promyelocytic leukemia proteinThe potential application of a transcriptionally regulated oncolytic herpes simplex virus for human cancer therapy.Bugs and drugs: oncolytic virotherapy in combination with chemotherapy.Advance in herpes simplex viruses for cancer therapy.Chemotherapy and Oncolytic Virotherapy: Advanced Tactics in the War against Cancer.Epithelial-mesenchymal transition enhances response to oncolytic herpesviral therapy through nectin-1.Concurrent chemotherapy inhibits herpes simplex virus-1 replication and oncolysis.Oncolytic herpes simplex virus vectors and taxanes synergize to promote killing of prostate cancer cells.Oncolytic adenoviral mutants with E1B19K gene deletions enhance gemcitabine-induced apoptosis in pancreatic carcinoma cells and anti-tumor efficacy in vivo.A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol.Chemovirotherapy of Pancreatic Adenocarcinoma by Combining Oncolytic Vaccinia Virus GLV-1h68 with nab-Paclitaxel Plus Gemcitabine.Complementary effects of HDAC inhibitor 4-PB on gap junction communication and cellular export mechanisms support restoration of chemosensitivity of PDAC cells.Targeted delivery of a suicide gene to human colorectal tumors by a conditionally replicating vaccinia virus.
P2860
Q21245717-282F265D-86BA-46DC-8EA8-2BBB8759E735Q26830620-02D4E587-1817-4B3D-92DF-AE4DE2104F15Q33289822-137E714F-D018-4F33-85B7-AFDA2FF8748FQ33828697-450641A7-FFC9-40BF-BC00-15DE8195D66CQ33887850-7B059B14-4E4F-41FE-8BA8-244C89E9BE18Q33924515-AFE33794-0F22-4D0D-83DB-5254CEA7D585Q33995471-9DCDA3E3-9342-4162-9551-8BFE768315D8Q34287746-D35B4C92-A0DF-4D93-8A21-85345CEE93CBQ35078434-992C4ACB-CCDD-471C-93D9-528AEAA7BFE0Q35785227-FB907551-A7C1-4249-B93B-57BB6BABA7A4Q36058012-8C0F87F4-CE5A-4536-A1A2-60EEAEAEF573Q37031896-55AAD086-E885-468E-84C6-8F7464CEEC0CQ37158534-408316B5-27FF-410E-91AA-0F48DFB5EE08Q37290808-E82B33E1-AAD9-476E-8C8F-C2F13480AF74Q37459624-31B6583A-416B-4372-AB60-60C2E7BD6672Q37899223-F4783048-9AD9-46B8-8ABF-9442F4103809Q38096940-8828FACB-C5A3-4456-937A-A5F8A1DDA4BFQ38223419-55FE65FA-F02A-47AB-B88B-D6BEA667DE5DQ39020984-99F6B2AC-B1D6-499B-8628-CA7C8C08797DQ39205115-ED0E1690-EBBE-4FD3-8B3A-98695F1929D4Q39745964-3DDFF45E-F297-4A41-8C52-5461725F930BQ39882822-90E39046-A92A-4868-A447-2B34AF6B8A3BQ40066397-2AB571D5-84BA-4525-AF43-05F3E2FBED86Q40162348-1553EEC0-2C0B-4D6E-9991-31AB30CD5007Q40197237-F0C861F2-1EB2-40C1-B4E3-C96E8E8094D9Q43493342-135BE5C2-B560-4636-9718-C233A3CC4612
P2860
5-fluorouracil and gemcitabine potentiate the efficacy of oncolytic herpes viral gene therapy in the treatment of pancreatic cancer
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
5-fluorouracil and gemcitabine ...... treatment of pancreatic cancer
@ast
5-fluorouracil and gemcitabine ...... treatment of pancreatic cancer
@en
5-fluorouracil and gemcitabine ...... treatment of pancreatic cancer
@nl
type
label
5-fluorouracil and gemcitabine ...... treatment of pancreatic cancer
@ast
5-fluorouracil and gemcitabine ...... treatment of pancreatic cancer
@en
5-fluorouracil and gemcitabine ...... treatment of pancreatic cancer
@nl
prefLabel
5-fluorouracil and gemcitabine ...... treatment of pancreatic cancer
@ast
5-fluorouracil and gemcitabine ...... treatment of pancreatic cancer
@en
5-fluorouracil and gemcitabine ...... treatment of pancreatic cancer
@nl
P2093
P2860
P1476
5-fluorouracil and gemcitabine ...... treatment of pancreatic cancer
@en
P2093
David P Eisenberg
Karen J Hendershott
Mei-Ki Chan
Michael Mullerad
Prasad S Adusumilli
Ting-Chao Chou
Zhenkun Yu
P2860
P2888
P304
1068-77; discussion 1077-9
P356
10.1016/J.GASSUR.2005.06.024
P50
P577
2005-11-01T00:00:00Z
P5875
P6179
1037816799